DNUT vs REGN · rev $1.67B vs P/E 14, rev $14.34B
Krispy Kreme Inc (DNUT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Krispy Kreme Inc (DNUT) is a grocery stores company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DNUT revenue for 2024-12-29 was $1.67B. Net income was $3.8M. Revenue was down 1.2% from 2023-12-31 to 2024-12-29. DNUT currently screens at market cap $605.1M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DNUT currently screens at market cap $605.1M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DNUT and REGN stock pages for the full models.
Not investment advice.